These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6492402)

  • 1. [Abnormal bile acids in acute and chronic hepatitis].
    Tanaka N
    Nihon Rinsho; 1984 Jul; 42(7):1597-603. PubMed ID: 6492402
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis: a dose-response study.
    Crosignani A; Battezzati PM; Setchell KD; Camisasca M; Bertolini E; Roda A; Zuin M; Podda M
    Hepatology; 1991 Feb; 13(2):339-44. PubMed ID: 1671665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bile acids in chronic hepatopathies].
    Luciani A; Massari M; Montanari P; Nora A; Zandomeneghi R
    Minerva Med; 1986 Dec; 77(49-50):2287-92. PubMed ID: 3808385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bile acid metabolism in patients with chronic hepatitis and liver cirrhosis].
    Klemashev IS; Dorofeev AA
    Sov Med; 1984; (6):44-6. PubMed ID: 6463746
    [No Abstract]   [Full Text] [Related]  

  • 5. [Determination of glycoconjugated biliary acids in the serum of chronic hepatitis patients and their correlation with liver function tests].
    Velo Bellver JL; Rabago Torre L; Fernández-Pacheco I; Castellanos D; Menchen PL; Clemente G; Senent C; López de la Riva M; Alcala Santaella R
    Rev Esp Enferm Apar Dig; 1983 Nov; 64(5):382-8. PubMed ID: 6658130
    [No Abstract]   [Full Text] [Related]  

  • 6. Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism.
    Crosignani A; Podda M; Bertolini E; Battezzati PM; Zuin M; Setchell KD
    Hepatology; 1991 Jun; 13(6):1076-83. PubMed ID: 2050325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of high resolution liquid chromatography to the test of bile acid tolerance].
    Marotta F; Hashimoto L; Safran P
    G Clin Med; 1990 Jan; 71(1):31-6. PubMed ID: 2365167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bile acids in acute hepatitis and in hepatitis with a chronic course].
    de la Vega Vázquez JM; Vahí Serrano S; Holgado Silva C; Sánchez Burgos R; Pineda Albornoz A; Aznar Martín A; Gómez Rodriquez F; Aznar Reig A
    Rev Clin Esp; 1982 Feb; 164(4):259-62. PubMed ID: 7089347
    [No Abstract]   [Full Text] [Related]  

  • 9. [Significance and limitations of oral UDCA loading in liver function test].
    Matsuzaki Y; Osuga T; Shoda J; Imawari M; Mitamura K
    Nihon Rinsho; 1984 Jul; 42(7):1671-6. PubMed ID: 6492410
    [No Abstract]   [Full Text] [Related]  

  • 10. [Free and bound bile acids in sera of patients with acute and chronic hepatitis].
    Sawaryn T
    Przegl Epidemiol; 1977; 31(2):157-64. PubMed ID: 882684
    [No Abstract]   [Full Text] [Related]  

  • 11. Conjugated and unconjugated serum bile acid levels n patients with hepatobiliary diseases.
    Makino I; Nakagawa S; Mashimo K
    Gastroenterology; 1969 Jun; 56(6):1033-9. PubMed ID: 5788911
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantification of individual serum bile acids in patients with liver diseases using high-performance liquid chromatography.
    Okuda H; Obata H; Nakanishi T; Hisamitsu T; Matsubara K; Watanabe H
    Hepatogastroenterology; 1984 Aug; 31(4):168-71. PubMed ID: 6479837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of fasting serum bile acid in the long-term observation of chronic liver disease.
    Kishimoto Y; Hijiya S; Takeda I
    Am J Gastroenterol; 1985 Feb; 80(2):136-8. PubMed ID: 3970000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum bile acids in chronic liver diseases].
    Socha J; Bogoniowska Z; Szymański W; Pawłowska J; Janas R; Woźniewicz B
    Pediatr Pol; 1983 Mar; 58(3):263-9. PubMed ID: 6622132
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinico-diagnostic significance of the determination of bile acids in chronic liver diseases].
    Andreuzzi B; Vai C; Santese R; Andreuzzi P; Cantoni L
    Minerva Med; 1984 Mar; 75(13):749-56. PubMed ID: 6717831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Behavior of bile acids in the blood in chronic hepatic diseases. I. Chronic hepatitis].
    Vai C; Andreuzzi B; Santese R; Alberti A; Gelosa F
    G Clin Med; 1983; 64(5-6):182-91. PubMed ID: 6618053
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration.
    Crosignani A; Podda M; Battezzati PM; Bertolini E; Zuin M; Watson D; Setchell KD
    Hepatology; 1991 Dec; 14(6):1000-7. PubMed ID: 1959845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter randomized controlled dose study of ursodeoxycholic acid for chronic hepatitis C.
    Takano S; Ito Y; Yokosuka O; Ohto M; Uchiumi K; Hirota K; Omata M
    Hepatology; 1994 Sep; 20(3):558-64. PubMed ID: 7521313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathological changes in serum bile acids in acute and chronic hepatitis].
    Cimino T; Spezia C; Marietti G
    Arch Sci Med (Torino); 1980; 137(3):471-5. PubMed ID: 7235935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An improved high-performance liquid-chromatographic determination of conjugated bile acids in serum using paired-ion chromatography.
    Hernanz A; Codoceo R
    Clin Chim Acta; 1985 Jan; 145(2):197-203. PubMed ID: 3971591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.